California Home
Welcome to California - images of Golden Gate Bridge, ocean sunset, waterfall, flowers, and city skyline

OEHHA Home

Air

About OEHHA

Children's Health

Ecotoxicology

Fish

Pesticides

Proposition 65

Public Information

Risk Assessment

Water

Reference Links

Help!

Site Map

OEHHA Listserver

Prop. 65 Listserver

Contact OEHHA Staff

OEHHA link to home page
 Proposition 65 - Meeting/Workshop Materials
Staff Presentations for Carcinogen Identification Committee Meeting Held on December 17, 2002
[11/14/03]

A meeting of the Carcinogen Identification Committee (CIC) was held on December 17, 2002, at the California Environmental Protection Agency Headquarters Building in Sacramento, California. Below are the presentations made by staff of California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA). The segments of the agenda covered by this material include the “Consideration of a Chemical Known to the State to Cause Cancer,” “Consideration of Chemicals, Listed Via the State’s Qualified Experts Mechanism, For Removal From the List,” and “Consideration of Request to Review Statin Drugs as a Group for Subsequent Listing Consideration.”

The CIC determined that phenelzine and its acid salts had not been clearly shown to cause cancer; and therefore, phenelzine and its acid salts are not added to the Proposition 65 chemical list. The CIC requested OEHHA to recommend to the National Toxicology Program that phenelzine salts be tested by the Program in long-term carcinogenesis bioassays. The CIC also determined that sodium saccharin, in light of new, relevant information, had not been clearly shown to cause cancer and should not remain on the Proposition 65 chemical list. Sodium saccharin will be removed from the Proposition 65 chemical list. In consideration of the request to review statin drugs as a group for subsequent listing consideration, the CIC recommended that OEHHA prepare individual hazard identification documents as resources are available on each of statin drugs and present them to the CIC at a future meeting. The CIC at that time would consider each of the statin drugs individually for possible listing. Related to the discussion surrounding statin drugs, the CIC expressed dissatisfaction with the present random selection aspect of the prioritization process. The CIC asked OEHHA to provide a proposal at a future CIC meeting for revisiting the current prioritization process and to bring together a subcommittee to discuss possible revisions.

Meeting Agenda

Consideration of Chemicals Known to the State to Cause Cancer
Phenelzine and its Acid Salts
Sara Hoover, M.S. and Brian Endlich, Ph.D., OEHHA

Consideration of Chemicals, Listed Via the State’s Qualified Experts Mechanism, For Removal From the List
Sodium Saccharin
Gail Krowech, Ph.D., Brian Endlich, Ph.D., and Martha Sandy, Ph.D., OEHHA

Consideration of Request to Review Statin Drugs as a Group for Subsequent Listing Consideration
Martha Sandy, Ph.D., OEHHA


You will need the free program Adobe Acrobat Reader to view or print PDF files Go to the Adobe web site

For questions regarding Proposition 65, please contact the Cynthia Oshita in the Proposition 65 Implementation Program

For help with this web site please contact the Web Mistress



OEHHA My CA
Proposition 65 Links


What's New

Current List of Chemicals

Safe Harbor Numbers
(NSRLs/MADLs)

Calendar

General Background

Proposition 65 Frequently Asked Questions

Workshop/Meeting Materials

CRNR Notices

Administrative Listing Mechanisms

State's Qualified Experts Mechanism

Law/Regulations/ Rulemaking Activity

Policy and Procedure documents

Toxicity Criteria Database